Raloxifene (Raloxifene) – Patient Information (UK)

Raloxifene is a medicine used to help prevent and treat certain bone-related conditions and to reduce the risk of specific breast cancer types in some post-menopausal women. It belongs to a group of medicines called selective oestrogen receptor modulators (SERMs).

This guide is designed to be patient-friendly and helpful for people considering or already using raloxifene. It explains what it does, how it works, how it is taken, common safety considerations, and what to discuss with a healthcare professional.

Quick product overview

How raloxifene works (mechanism of action)

Raloxifene acts on oestrogen receptors in different tissues in different ways:

• Bone (anti-resorptive effect): Raloxifene behaves like an oestrogen-like medicine in bone. This helps slow down bone breakdown, which can improve bone strength and reduce the chance of vertebral fractures.
• Breast and uterus: In some breast tissues, raloxifene may reduce the effects of oestrogen. It is used to lower the risk of oestrogen-receptor positive breast cancer in post-menopausal women who are appropriate candidates.
  Important: Its effects on the uterus differ from those on bone, so abnormal uterine bleeding should still be taken seriously.
• Blood clot risk: Like other SERMs, raloxifene can increase the tendency for blood clots in some situations (details below).

What raloxifene is used for (indications)

In the UK, raloxifene is used for specific approved purposes, typically in post-menopausal women. Indications may vary by product licence and patient characteristics. Common approved uses include:

• Prevention and/or treatment of osteoporosis in post-menopausal women, particularly to reduce the risk of vertebral fractures.
• Reducing risk of oestrogen-receptor positive breast cancer in post-menopausal women at risk, as assessed by a clinician.

Because both osteoporosis and breast cancer risk depend on individual risk factors, your healthcare professional will decide whether raloxifene is a suitable option for you.

Pharmacokinetics (how the body processes it)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. Key points for raloxifene include:

• Absorption: After taking a tablet, raloxifene is absorbed from the gut. The medicine reaches peak levels in the bloodstream after a few hours.
• Distribution: Raloxifene is highly protein-bound. It can also undergo enterohepatic recirculation, meaning some of the medicine may be re-processed in the liver and then returned to the digestive tract.
• Metabolism: It is metabolised mainly in the liver.
• Elimination: It is eliminated primarily via the bile and faeces. Kidney clearance is not the dominant pathway, but kidney function should still be considered for suitability.
• Half-life: Raloxifene has a long half-life, supporting once-daily dosing in many cases.

For most people, the standard dosing regimen achieves steady exposure over time. Your clinician may adjust the plan if you have liver problems or other risk factors.

Typical dosing and timing

The usual adult dosing for the common tablet strength is:

• Raloxifene: 60 mg once daily (unless advised otherwise for your specific product/plan).

Timing: Take your dose at the same time each day to help you remember. Many people choose a morning routine or an evening routine depending on lifestyle. You can take it with or without food.

If you miss a dose:

• Take it when you remember on the same day.
• If it is close to the time of the next dose, skip the missed dose and continue as normal.
• Do not take double the dose to make up for a missed one.

Course length: In osteoporosis, benefits build over months. In breast cancer risk reduction, it is typically used as a preventative measure over time. Regular reviews with your clinician are important.

Food interactions

Raloxifene can usually be taken with or without food. No specific food group is universally prohibited, and most people do not need to change their diet when starting therapy.

However, overall bone health and breast risk reduction plans often include lifestyle measures such as:

• adequate calcium intake (from diet and/or supplements if advised)
• adequate vitamin D
• regular weight-bearing exercise
• smoking cessation and sensible alcohol intake

If you take other medicines (especially for cholesterol, seizures, or hormone-related therapies), it is important to check for interactions. Some medicines may affect absorption or oestrogen-related pathways indirectly.

Alcohol and medicine interactions

Alcohol: Moderate alcohol intake is generally not a direct contraindication for raloxifene, but it can affect bone health and may worsen side effects such as hot flushes or dizziness in some people.

Practical approach:

• If you drink alcohol, keep it moderate and consistent.
• If you notice symptoms (such as flushing, light-headedness, or unusual bleeding), consider reducing alcohol and speak to a clinician.
• If you have liver disease or drink heavily, ask for tailored advice.

Medicine interactions: Raloxifene has clinically relevant interactions mainly with medicines that affect liver metabolism or that influence clotting risk. Examples of medicines that should be discussed with a healthcare professional include:

• Hormone-containing therapies (including some oestrogen products): using raloxifene alongside oestrogen can counteract intended effects.
• Other medicines associated with blood clot risk: the overall risk may increase when combined.
• Medicines affecting hepatic metabolism: some drugs can alter raloxifene exposure.

Always tell your pharmacist or clinician about all medicines and supplements you take, including herbal products.

Safety profile and important warnings

Like all medicines, raloxifene can cause side effects. Some are common and manageable; others are rare but serious. Before taking it, discuss your personal risk factors for blood clots and any history of breast or liver conditions.

Common side effects

• Hot flushes (vasomotor symptoms)
• Leg cramps or muscle discomfort
• Swelling (e.g., peripheral oedema) in some people
• Headache
• Nausea or mild stomach upset
• Flu-like symptoms in some cases

Serious side effects (seek urgent help)

Raloxifene may increase the risk of blood clots in certain circumstances. Seek urgent medical attention if you develop symptoms suggestive of a clot:

• Sudden shortness of breath, chest pain, coughing blood (possible pulmonary embolism)
• Unilateral leg swelling, pain, warmth, redness (possible deep vein thrombosis)
• Sudden weakness, facial droop, trouble speaking (possible stroke)

Also contact a clinician promptly if you experience:

• Unusual vaginal bleeding or bleeding after menopause
• Severe or persistent abdominal pain, especially with liver concerns

Who should take extra care or avoid raloxifene

Raloxifene may not be suitable for everyone. Extra caution is particularly important if you:

• have a current or past history of blood clots (DVT/PE)
• are at higher risk of clotting due to conditions such as prolonged immobility or certain medical histories
• have severe liver disease (as exposure may be higher)
• have certain untreated uterine conditions or unexplained abnormal bleeding

Stopping before surgery or during immobilisation

The clot risk can rise with immobilisation (for example after major surgery). Many SERMs require a planned approach around periods of immobilisation. Speak to your clinician well in advance if you have:

• planned surgery
• hospital admission
• expected long travel with limited movement
• casting/bracing that reduces mobility

Your clinician may advise stopping raloxifene temporarily and restarting when it is safe.

Practical use tips

• Choose a consistent time: Taking the tablet at the same time daily improves adherence.
• Keep a medication routine: Link it with a daily habit (e.g., breakfast or bedtime).
• Stay mobile: Regular walking can help reduce clot risk, particularly during longer periods at home.
• Report bleeding promptly: Any new abnormal vaginal bleeding should be assessed.
• Support bone health: If you have osteoporosis, maintain adequate calcium and vitamin D intake and consider weight-bearing exercise.
• Know the warning signs: Be alert for symptoms of clots (shortness of breath, leg swelling/pain).

Alternative options for osteoporosis and breast cancer risk reduction

Treatment choices depend on the goal (fracture prevention, bone density improvement, or breast cancer risk reduction), your medical history, and your risk profile. Alternatives may include:

For osteoporosis

• Bisphosphonates (e.g., alendronate, risedronate, zoledronic acid) – reduce fracture risk and slow bone loss.
• Denosumab – an injection that helps reduce fracture risk.
• Hormone replacement therapy or other bone-active agents in selected cases (decision depends on breast/uterus risk and suitability).
• Other SERMs (e.g., medicines in the same class may be used for specific indications, depending on licence and patient factors).

For breast cancer risk reduction

• Tamoxifen or other relevant endocrine therapies in selected patient groups (choices depend strongly on menopausal status and risk profile).
• Non-medicine strategies (where appropriate): lifestyle measures, risk assessment, and structured screening plans.

If raloxifene is not suitable or you experience side effects, a clinician can discuss the most appropriate alternative based on your individual risk and preferences.

United Kingdom: market, regulatory and guidance context

In the UK, medicines are authorised and monitored through regulatory and safety systems, including:

• MHRA (Medicines and Healthcare products Regulatory Agency)
• Yellow Card reporting for suspected adverse drug reactions
• Clinical guidance that may evolve over time via UK health bodies

Recommendations for osteoporosis and breast cancer prevention are regularly reviewed and updated as new evidence becomes available. For the most current advice, it is appropriate to follow guidance from UK organisations and to discuss your personal plan with your clinician.

Recent guidance note (general): Over recent years, emphasis has continued on:

• individualised fracture and cancer risk assessment
• reviewing clot risk with SERMs, especially around periods of immobility
• ensuring adequate calcium/vitamin D support where appropriate
• monitoring for new symptoms (especially leg swelling, breathlessness, or abnormal bleeding)

Delivery, availability and packaging (UK online pharmacy)

Availability can vary by brand and strength. When ordering online in the UK, your selected product may be supplied as:

• single packs (one box)
• multipacks (multiple tablets in one delivery, depending on availability)

Delivery: Typical delivery options include standard and expedited services, and you may be able to track your order. Delivery times depend on stock levels and your postcode.

Storage: Store tablets according to the instructions on the pack (commonly at room temperature, away from excess heat and moisture). Keep out of sight and reach of children.

If you require assistance (for example, about dosage forms or availability), support from the pharmacy team can help you confirm the correct product.

FAQ about raloxifene

1) Is raloxifene the same as oestrogen?

No. Raloxifene is a SERM. It affects oestrogen receptors differently in different body tissues. It can act like an oestrogen in bone, while acting differently in breast and uterus tissues.

2) How long does it take to work for osteoporosis?

Bone improvements take time. Many people notice benefits over months, while fracture risk reduction is assessed over longer periods. Your clinician will schedule reviews and may repeat bone density tests depending on your situation.

3) Can I take raloxifene with food?

Usually yes. Raloxifene can typically be taken with or without food. Choose what is easiest for you and stick with a consistent routine.

4) What side effects are most common?

Hot flushes, leg cramps, headache, nausea, and mild swelling can occur. Most side effects are not severe, but persistent or worrying symptoms should be discussed.

5) Who is at higher risk of blood clots with raloxifene?

Risk increases with personal history of clots, certain medical conditions, smoking, long periods of immobility, and around major surgery. Tell your clinician about any clot history and any planned travel or operations.

6) What should I do if I’m having surgery or will be immobile?

Contact your clinician as early as possible. They may advise stopping raloxifene temporarily and implementing measures to reduce clot risk during the immobilisation period.

7) Can I drink alcohol while taking raloxifene?

Moderate alcohol is usually acceptable for many people, but it may worsen symptoms such as hot flushes or dizziness and can affect bone health. If you drink heavily or have liver problems, seek individual advice.

8) Can raloxifene affect cholesterol or other blood tests?

It may have effects on some lipid parameters in certain people. Routine blood tests should be interpreted in context, and any unusual results should be discussed with a clinician.

9) Will raloxifene cause changes to menstrual bleeding?

Since raloxifene is used in post-menopausal women, vaginal bleeding is not expected. If you experience any bleeding, you should seek medical assessment promptly.

10) Are there any alternatives if I can’t tolerate raloxifene?

Yes. Depending on the reason you’re taking it (osteoporosis or breast cancer risk reduction), options may include other bone medicines or endocrine therapies. A clinician can discuss the best alternative based on your risk profile and preferences.

When to seek urgent medical advice

Contact urgent medical services or seek immediate help if you experience symptoms that may indicate a blood clot or stroke, such as:

• shortness of breath or chest pain
• one leg becoming swollen, painful, warm or red
• sudden weakness, facial droop, trouble speaking

For less urgent but still important concerns (persistent hot flushes, new swelling, or any abnormal vaginal bleeding), contact a clinician promptly.

Note: This information is a general guide for patients in the UK. Individual suitability depends on your medical history, current medications, and risk factors. If you have questions about raloxifene or interactions with other treatments, consult a pharmacist or clinician.